407 publications

Name Date Type Actions

Clone of Buyback programs – April 2023

Monthly communication regarding buyback programs

 		05/04/2023 Monthly communication regarding buyback programs

Buyback programs – May 2023

Monthly communication regarding buyback programs

 		05/04/2023 Monthly communication regarding buyback programs

Buyback programs – June 2023

Monthly communication regarding buyback programs

 		05/04/2023 Monthly communication regarding buyback programs

[VIDEO] Présentation des résultats annuels 2022 -French

Présentation analystes & investisseurs - 23 Mars 2023

 		23/03/2023 Annual Report

ANNUAL RESULTS 2022 (slideshow)

01.2022 Highlights
02.2022 Consolidated financial statements
03.Strategy and outlook

 		23/03/2023 Annual Report

2022 ANNUAL RESULTS

Annual sales: €540m (up 3.6% as reported)
Essentials sales: €304m (up 4.5% as reported)
EBIT before depreciation of acquired assets: €99m (18.3% of sales)
Net income - Group share: €48m (8.9% of sales)
EBITDA: €118m (21.9% of sales)
Free cash-flow: €63m

 		23/03/2023 Public releases

Annual sales 2022

Total group Sales: €540 million (up 3.6% as reported)
Annual Sales of Essential products: €304 million (up 4.5% as reported)

 		18/01/2023 Public releases

First nine months 2022 sales: €405M

In line with year-end outlook

 		12/10/2022 Public releases

2022 HALF YEAR RESULTS Additional information on the Group’s strategy

Following the conference call organised on 15 September 2022 to present its half-year results, Vetoquinol would like to provide some additional information on the strategy implemented and its outlook.

 		23/09/2022 Public releases , Half Year Report

2022 HALF YEAR RESULTS

Sales: €271m (up 6.0% as reported)
Essentials sales: €154m (up 9.8% as reported)
EBIT before depreciation of acquired assets: €52m (19.0% of sales)
Net income - Group share: €21m (7.9% of sales)
EBITDA: €62m (22.9% of sales)

 		15/09/2022 Public releases